Skip to Main Content
Back to News

ANNOVIS BIO -REDH Earnings Results: $ANVS Reports Quarterly Earnings

None

ANNOVIS BIO -REDH ($ANVS) posted quarterly earnings results on Tuesday, August 12th. The company reported earnings of -$0.32 per share, beating estimates of -$0.41 by $0.09. The company also reported revenue of $0, equaling estimates of $0 by $0.

You can see Quiver Quantitative's $ANVS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

ANNOVIS BIO -REDH Hedge Fund Activity

We have seen 24 institutional investors add shares of ANNOVIS BIO -REDH stock to their portfolio, and 16 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

ANNOVIS BIO -REDH Analyst Ratings

Wall Street analysts have issued reports on $ANVS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • HC Wainwright & Co. issued a "Buy" rating on 06/09/2025
  • Canaccord Genuity issued a "Buy" rating on 05/15/2025

To track analyst ratings and price targets for ANNOVIS BIO -REDH, check out Quiver Quantitative's $ANVS forecast page.

ANNOVIS BIO -REDH Price Targets

Multiple analysts have issued price targets for $ANVS recently. We have seen 2 analysts offer price targets for $ANVS in the last 6 months, with a median target of $14.5.

Here are some recent targets:

  • Raghuram Selvaraju from HC Wainwright & Co. set a target price of $12.0 on 06/09/2025
  • Sumant Kulkarni from Canaccord Genuity set a target price of $17.0 on 05/15/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles